Treatment for irritable bowel syndrome
AssigneeResearch Corporation Technologies, Inc.
InventorsThomas F. Burks, Cynthia A. Williams
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treatment of functional bowel disease in mammals. More specifically, this invention contemplates prophylaxis and treatment of functional bowel disease in mammals by the administration of antagonists of corticotropin releasing factor. The present invention also relates to pharmaceutical compositions of these antagonists useful in the treatment of functional bowel disease in mammals.
Claims5
A method of inducing regression of functional bowel disease in a mammal comprising the administration to said mammal of an effective amount of an antagonist to corticotropin-releasing factor (CRF).
Dependencies are inferred from the claim text.